000			02042 a2200589 4500
005			20250517025653.0
264		0	_c20160607
008			201606s 0 0 eng d
022			_a2050-6511
024	7		_a10.1186/s40360-015-0001-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aLambrechts, Sandrina
245	0	0	_aGenetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. _h[electronic resource]
260			_bBMC pharmacology & toxicology _cFeb 2015
300			_a2 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnemia _xchemically induced
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aCarrier Proteins _xgenetics
650	0	4	_aColony-Stimulating Factors _xadverse effects
650	0	4	_aDNA Repair _xgenetics
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHematinics _xadverse effects
650	0	4	_aHumans
650	0	4	_aInactivation, Metabolic _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aMultidrug Resistance-Associated Protein 2
650	0	4	_aNeurotoxicity Syndromes _xgenetics
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aPolymorphism, Single Nucleotide _xgenetics
650	0	4	_aThrombocytopenia _xchemically induced
650	0	4	_aYoung Adult
700	1		_aLambrechts, Diether
700	1		_aDespierre, Evelyn
700	1		_aVan Nieuwenhuysen, Els
700	1		_aSmeets, Dominiek
700	1		_aDebruyne, Philip R
700	1		_aRenard, Vincent
700	1		_aVroman, Philippe
700	1		_aLuyten, Daisy
700	1		_aNeven, Patrick
700	1		_aAmant, Frédéric
700	1		_aLeunen, Karin
700	1		_aVergote, Ignace
773	0		_tBMC pharmacology & toxicology _gvol. 16 _gp. 2
856	4	0	_uhttps://doi.org/10.1186/s40360-015-0001-5 _zAvailable from publisher's website
999			_c24811696 _d24811696